What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
Sustained abstinence is currently the only accepted end-point for pharmacotherapy trials for most substance use disorders (SUD), with the exception of alcohol. Despite recent efforts, the identification of a non-abstinence alternative as a clinically meaningful end-point for drug use trials has been...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Další autoři: | |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Témata: | |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky: What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
- Cigarette smoke directly impairs skeletal muscle function through capillary regression and altered myofiber calcium kinetics in mice
- Brief school-based interventions and behavioural outcomes for substance-using adolescents (Review)
- Public health consequences of e-cigarettes
- Costs and unintended consequences of drug control policies
- The effectiveness of self-directed medical cannabis treatment for pain
- Usages de drogues en prision. Pratiques, conséquences et réponses